Back to funds
View filing
BML Capital Management, LLC
hedge fundUpdated 35 days agoManaged by Bml Capital Management, Llc • Latest filing Q2 2026
Portfolio value
$176.1M
Q2 2026
Filings
13
Quarterly 13F history
Top-10 concentration
99.5%
Weight of largest holdings
Annualized return
-7.9%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 13 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q2 2023 | $111.2M |
| Q3 2023 | $108.9M |
| Q4 2023 | $131.1M |
| Q1 2024 | $149.4M |
| Q2 2024 | $140.1M |
| Q3 2024 | $169.9M |
| Q4 2024 | $161M |
| Q1 2025 | $123.6M |
| Q2 2025 | $132.2M |
| Q3 2025 | $109.2M |
| Q4 2025 | $115.7M |
| Q1 2026 | $155.8M |
| Q2 2026 | $176.1M |
Top holdings
18 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A ACRS ACLARIS THERAPEUTICS INC | $63.3M | 11.97M | 35.98% | — |
| 2 | ? N/A ATEA PHARMACEUTICALS INC | $32.3M | 6.95M | 18.36% | — |
| 3 | E ENGNW ENGENE THERAPEUTICS INC | $11.5M | 6.67M | 6.55% | — |
| 4 | K KHC KRAFT HEINZ CO | $11M | 465.0K | 6.24% | — |
| 5 | ? N/A OUTSET MED INC | $10.9M | 2.52M | 6.18% | — |
| 6 | K KMX CARMAX INC | $9.1M | 172.5K | 5.18% | — |
| 7 | T TDGMW TILLYS INC | $9M | 2.15M | 5.13% | — |
| 8 | P PPLC PMV PHARMACEUTICALS INC | $7.1M | 5.33M | 4.06% | — |
| 9 | ? N/A INSTIL BIO INC | $5M | 645.6K | 2.82% | — |
| 10 | T TGT TARGET CORP | $4.9M | 37.5K | 2.78% | — |
| 11 | O ORMP ORAMED PHARMACEUTICALS INC | $4.2M | 866.3K | 2.37% | — |
| 12 | ? N/A JANUX THERAPEUTICS INC | $2.4M | 155.0K | 1.35% | — |
| 13 | ? N/A PLIANT THERAPEUTICS INC | $1.8M | 1.55M | 1.00% | — |
| 14 | C CNTB CONNECT BIOPHARMA HLDGS LTD | $1.4M | 573.3K | 0.78% | — |
| 15 | I IMA IMAGENEBIO INC | $1.2M | 200.7K | 0.67% | — |
| 16 | W WMT WALMART INC | $386K | 335 | 0.22% | — |
| 17 | C CORZR CORE SCIENTIFIC INC NEW | $298K | 800 | 0.17% | — |
| 18 | T TSLA TESLA INC | $270K | 375 | 0.15% | — |